In Defense of Evidence-based Medicine for the Treatment of COVID-19 Acute Respiratory Distress Syndrome | Annals of the American Thoracic Society

Severe acute respiratory failure from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) has challenged intensivists worldwide with both increased severity of illness and quantity of patients. An extraordinary amount has been published about presentation, treatment, and outcomes of these patients in both medical journals and social media. Less than 6…

Read the full article here

Related Articles